APA aipamena

Lerman, D. M., Monument, M. J., McIlvaine, E., Liu, X., Huang, D., Monovich, L., . . . Lessnick, S. L. (2014). Tumoral TP53 and/or CDKN2A Alterations are Not Reliable Prognostic Biomarkers in Patients with Localized Ewing Sarcoma: A Report from the Children’s Oncology Group. Pediatr Blood Cancer.

Chicago Style aipamena

Lerman, Daniel M., et al. "Tumoral TP53 And/or CDKN2A Alterations Are Not Reliable Prognostic Biomarkers in Patients With Localized Ewing Sarcoma: A Report From the Children’s Oncology Group." Pediatr Blood Cancer 2014.

MLA aipamena

Lerman, Daniel M., et al. "Tumoral TP53 And/or CDKN2A Alterations Are Not Reliable Prognostic Biomarkers in Patients With Localized Ewing Sarcoma: A Report From the Children’s Oncology Group." Pediatr Blood Cancer 2014.